Immunosuppression with purine analogues--the flip side of the gold coin

Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy.

Leukemia·2017

ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).

Blood cancer journal·2016

New Agents and Strategies in CLL Treatment.

Leukemia & lymphoma·2016

Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.

Leukemia & lymphoma·2016

Adhesion of B-Cell Chronic Lymphocytic Leukemia Cells to Marrow Stromal Cells is Mediated by α4β1 but not β2αL Integrin: MSC also Prevent Apoptosis of B-CLL Cells.

Hematology (Amsterdam, Netherlands)·2016

Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.

Oncogene·2016

Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Emerging Therapeutic targets and Early-phase drug Development in Gynecological Malignancies.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Targeted physical therapy for gouty arthritis: a first-principles frequency-screening study.

Frontiers in physiology·2026

Repurposed catechol-O-methyltransferase inhibitors tolcapone and entacapone preferentially suppress aggregation and seeding of P301 mutant tau in human neuronal models.

British journal of pharmacology·2026

De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry.

Bioconjugate chemistry·2026

Cysteine/GSH-Responsive Lipid Switch Development for Liposome Triggered Cargo Release.

Bioconjugate chemistry·2026

China's Order 818: A New Commercialization Pathway Reshaping Cell and Gene Therapy.

Omics : a journal of integrative biology·2026

Sonolucent cranial windows for bedside ultrasound identification of MRI-concordant glioblastoma recurrence during outpatient surveillance: an imaging correlation pilot study.

Acta neurochirurgica·2026

Related Experiment Videos

Immunosuppression with purine analogues--the flip side of the gold coin

Related Concept Videos

Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy.

ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).

New Agents and Strategies in CLL Treatment.

Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.

Adhesion of B-Cell Chronic Lymphocytic Leukemia Cells to Marrow Stromal Cells is Mediated by α4β1 but not β2αL Integrin: MSC also Prevent Apoptosis of B-CLL Cells.

Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.

Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial.

Emerging Therapeutic targets and Early-phase drug Development in Gynecological Malignancies.

Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.

Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.

Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

Targeted physical therapy for gouty arthritis: a first-principles frequency-screening study.

Repurposed catechol-O-methyltransferase inhibitors tolcapone and entacapone preferentially suppress aggregation and seeding of P301 mutant tau in human neuronal models.

De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry.

Cysteine/GSH-Responsive Lipid Switch Development for Liposome Triggered Cargo Release.

China's Order 818: A New Commercialization Pathway Reshaping Cell and Gene Therapy.

Sonolucent cranial windows for bedside ultrasound identification of MRI-concordant glioblastoma recurrence during outpatient surveillance: an imaging correlation pilot study.

Related Experiment Videos

Immunosuppression with purine analogues--the flip side of the gold coin

Related Concept Videos

Related Articles